Sabrina serves as vice president and corporate controller at Latigo Biotherapeutics, bringing more than 15 years of experience in corporate accounting and operations.

Sabrina’s expertise includes initial public offering (IPO) readiness, establishing and strengthening internal controls, and operational excellence. Prior to Latigo, she served as corporate controller at private and publicly traded companies in the life sciences industry, where she led accounting operations and drove company-wide initiatives to enable scalability and support organizational growth.

Sabrina began her career in the assurance practice at EY, where she spent 10 years serving audit clients across a wide range of industries and stages of growth in both the U.S. and Europe. Sabrina is a Certified Public Accountant and received her U.S. master’s degree equivalent in business administration from Saarland University in Germany, and is currently a student with the Chartered Financial Analyst Institute.